Mounjaro and Foundayo are different medicines, so moving from one to the other is not a simple dose-for-dose swap. Switching from Mounjaro to Foundayo may be suitable for some people who prefer a daily tablet to weekly injections. However, the transition should be planned by a qualified prescriber based on your treatment history and individual circumstances.
A safe switch involves knowing when to start Foundayo after your final Mounjaro injection, how the starting dose is determined and what to monitor during the transition. This guide also explores whether an oral treatment may better suit your routine and what switching could mean for the weight-loss progress you have already made.
GLP-1
Foundayo
Daily GLP-1 support that helps control appetite, hunger, and cravings to support substantial, sustained weight loss.
- ✔Up to 12.4% average weight loss
- ✔Helps reduce hunger and cravings
- ✔Supports longer-lasting fullness
- ✔Clinically proven weight management
Key Facts About Switching to Foundayo
- ✔Switching from Mounjaro to Foundayo is possible, but should be supervised by a qualified prescriber.
- ✔Foundayo can usually be started around a week after the last Mounjaro injection, with timing confirmed by your prescriber.
- ✔There is no direct 1:1 dose conversion between the two treatments.
- ✔Foundayo provides a once-daily, needle-free alternative to weekly Mounjaro injections.
- ✔Clinical trials suggest Mounjaro may deliver greater average weight loss, although the studies were not head-to-head.
- ✔Early evidence suggests orforglipron may help maintain weight-loss progress after switching from injectable incretin treatment.
Is It Possible to Switch From Mounjaro to Foundayo?
Yes, switching from Mounjaro to Foundayo is possible, but the transition should be clinically supervised because they contain different active ingredients and work differently. Mounjaro contains tirzepatide, which targets both GLP-1 and GIP receptors, while Foundayo contains orforglipron, which targets the GLP-1 receptor alone.
Your prescriber will review your current Mounjaro dose, treatment response, side effects, medical history and overall health before recommending a switch. As the medicines are not directly equivalent, the transition should follow a prescriber-led plan rather than a self-selected dose change. Mounjaro and Foundayo should not be used together unless specifically directed by your prescriber.
Who Is Eligible to Switch From Mounjaro to Foundayo?
You may be eligible for switching from Mounjaro to Foundayo if a prescribing clinician approves the transition after reviewing your medical history and confirms that the daily oral treatment is suitable for you. This generally applies to adults already established on Mounjaro who remain eligible for medical weight management.
A switch may be considered if you:
- are currently established on Mounjaro and tolerating treatment
- prefer a once-daily tablet to weekly injections
- have difficulty with injections, such as needle anxiety or injection-site reactions
- remain clinically suitable for weight-management treatment
- are not pregnant or breastfeeding
- have no health conditions or treatment factors that make Foundayo unsuitable
You may not need to meet the original starting BMI threshold again if successful Mounjaro treatment has already reduced your weight. However, your current health, treatment response and previous weight history will still be reviewed. If Mounjaro was prescribed by another provider, you may also need to provide evidence of treatment, such as a prescription, dispensing label or relevant medical record.
Why Switch From Mounjaro Injections to Foundayo Tablets?
For many people, moving from weekly Mounjaro injections to Foundayo is more about convenience and treatment preference than achieving greater weight loss. Foundayo provides a once-daily, needle-free option that may be easier to incorporate into everyday life, although the potential benefits should be considered alongside differences in treatment effectiveness.
- Avoid injections: Foundayo is taken as a daily tablet, which may suit people with needle anxiety, injection-site discomfort or those who want to avoid pens, needles and sharps disposal.
- Create a simpler daily routine: Some people find it easier to take medication every day rather than remember an injection on the same day each week. Foundayo can also be taken with or without food, without fasting beforehand.
- Make travelling more convenient: Foundayo tablets can be easier to carry and manage away from home, without the additional planning associated with injection equipment and pen storage.
- Support longer-term weight management: People who have already made substantial progress with Mounjaro may prefer an oral treatment for the next stage of their weight-management plan, provided Foundayo remains clinically appropriate.
- Prioritise treatment convenience: For some people, the main reason for switching may be the convenience of oral treatment rather than an expectation of improving their weight-loss results.
These factors should be considered alongside your individual response to Mounjaro and your longer-term treatment goals. Your prescriber can determine whether Foundayo is an appropriate alternative based on your circumstances. Start an online consultation to have your treatment history and suitability reviewed by a qualified prescriber before making the switch.
How Does Weight Loss Compare Between Mounjaro and Foundayo?
Clinical trials suggest Mounjaro may produce greater average weight loss than orforglipron. In the 72-week SURMOUNT-1 trial, Mounjaro (tirzepatide) produced average weight loss of up to 22.5% at the 15 mg dose. In the 72-week ATTAIN-1 trial, orforglipron produced an average reduction of 12.4% at the 36 mg trial dose.
These results come from separate studies rather than a direct head-to-head trial, so they should not be treated as a like-for-like comparison. The 36 mg orforglipron research dose should also not be confused with current Foundayo dosing strengths. Individual results can vary according to dose, treatment response, tolerability, adherence and lifestyle factors.
How Soon After Mounjaro Can You Start Foundayo?
Foundayo can usually be started around one week after your final Mounjaro injection, when your next weekly dose would normally have been due. This allows a direct transition without an unnecessarily long treatment gap, although your prescriber should confirm the exact start date based on your treatment history and tolerability.
The first Foundayo dose is generally taken within 14 days of the last Mounjaro injection. If more than 14 days have passed, your treatment should be reviewed before switching, as you may need to start at a lower Foundayo dose. Do not overlap the two treatments unless specifically directed by your prescriber.
What Is the Starting Foundayo Dose After Mounjaro?
Your Foundayo starting dose may take your previous Mounjaro strength into account, but the transition should be determined by a prescriber. Even if you are established on a higher Mounjaro dose, Foundayo follows a different dosing and escalation schedule.
There Is No 1:1 Dose Conversion
Mounjaro contains tirzepatide, while Foundayo contains orforglipron. Their doses cannot be compared milligram for milligram, meaning 1 mg of Mounjaro does not equal 1 mg of Foundayo. Your previous dose can help inform the transition, but it does not automatically determine your Foundayo starting strength.
The table below provides an estimated switching guide based on your current Mounjaro dose:
| Current Mounjaro dose | Estimated Foundayo switching dose | ||||
|---|---|---|---|---|---|
| 2.5 mg once weekly | 5 mg once weekly | 7.5 mg once weekly | 10 mg once weekly | 12.5 mg once weekly | 15 mg once weekly |
| 0.8 mg once daily | 2.5 mg once daily | 5.5 mg once daily | 9 mg once daily | 9 mg once daily | 9 mg once daily |
These doses are estimated switching points rather than direct equivalents. Your prescriber may recommend a different starting dose depending on your response to Mounjaro, tolerability, current side effects and overall clinical circumstances.
Once Foundayo has been started, further dose increases should follow its prescribed titration schedule rather than your previous Mounjaro dose. Increases are generally made gradually, with at least 30 days between dose steps, and may be delayed if gastrointestinal side effects are troublesome.
Will You Regain Weight After Switching From Mounjaro to Foundayo?
Weight regain is not inevitable after switching from Mounjaro to Foundayo. Appetite control and weight changes may differ during the transition, but continuing prescribed treatment alongside balanced nutrition and regular physical activity can help maintain progress. Individual outcomes will depend on treatment response, adherence, dose and lifestyle habits over time.
Evidence from the ATTAIN-MAINTAIN trial suggests orforglipron can help maintain weight loss previously achieved with injectable incretin treatments, including tirzepatide. Participants switching to orforglipron maintained their progress better than those receiving placebo. However, longer-term switching data remain limited, so sustained weight regain or appetite changes should be discussed with your prescriber.
Conclusion: Making a Safe and Informed Switch
Moving from Mounjaro to Foundayo can offer a convenient oral alternative for people who want to move away from weekly injections. However, differences in how these medicines work, their dosing schedules and expected weight-loss outcomes mean the transition should always be planned with appropriate clinical guidance.
Whether Foundayo is suitable depends on your response to Mounjaro, treatment preferences and clinical circumstances. Following your prescribed plan and healthy lifestyle habits can support longer-term progress. Online Weight Loss Clinic provides clinician-led support to help you understand your options and make an informed treatment decision.
FAQs About Switching From Mounjaro to Foundayo
Can you take Foundayo with food after switching from Mounjaro?
Yes. Foundayo can be taken with or without food, so you do not need to fast before taking your daily tablet. Follow the dosing instructions provided by your prescriber.
What time of day should you take Foundayo?
Foundayo can be taken at any time of day. Taking it at a consistent time may make it easier to remember your daily dose and maintain your treatment routine.
What happens if you miss a dose of Foundayo?
If you miss a Foundayo dose, follow the instructions provided with your medicine rather than taking extra tablets to compensate. If you are unsure what to do, speak to your prescriber or pharmacist.
Can switching from Mounjaro to Foundayo cause side effects?
Yes. Foundayo can cause gastrointestinal side effects such as nausea, diarrhoea, vomiting, constipation and abdominal discomfort. Symptoms may be more noticeable when starting treatment or following a dose increase.
Can you drink alcohol while taking Foundayo?
There is no general requirement to completely avoid alcohol while taking Foundayo, but alcohol may worsen digestive side effects or make weight-management goals harder to maintain. Ask your prescriber if you have concerns about drinking during treatment.
Does Foundayo need to be kept in the fridge?
Follow the storage instructions supplied with your Foundayo tablets and keep them in their original packaging as directed. This differs from managing an injectable pen and may make the treatment more convenient when travelling.
Can Foundayo affect other medicines you take?
Foundayo may influence how quickly the stomach empties, which can be relevant to some oral medicines. Tell your prescriber about all prescription medicines, over-the-counter treatments and supplements you use before switching.
What should you do if Foundayo does not control your appetite as well as Mounjaro?
Appetite control may feel different after changing treatments. Do not increase your Foundayo dose yourself. If hunger increases significantly or your weight-management response changes, speak to your prescriber so they can review your dose, tolerability and treatment plan.
